In this study, we investigated the effect of chelidonine, an alkaloid component of <i>Chelidonium majus</i> L., on STAT3/Bcl-2 signaling in human T leukemia/lymphoma cells, reported to have numerous effects in common with microtubule-targeting agents (MTAs). This evidence concerns the gene STAT3 and lymphoma.